GSK’s anaemia drug gets FDA advisory committee support for patients on dialysis

31st October 2022 Uncategorised 0

A final decision for daprodustat by the FDA is expected by 1 February 2023

More: GSK’s anaemia drug gets FDA advisory committee support for patients on dialysis
Source: News